Related references
Note: Only part of the references are listed.Potential of Recombinant Opa Proteins as Vaccine Candidates against Hyperinvasive Meningococci
M. J. Callaghan et al.
INFECTION AND IMMUNITY (2011)
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
P. B. Keiser et al.
VACCINE (2011)
Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults
Pablo Bonvehi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Serogroup B meningococcal vaccines-an unfinished story
Manish Sadarangani et al.
LANCET INFECTIOUS DISEASES (2010)
A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA
Paul B. Keiser et al.
VACCINE (2010)
Opa+ and Opa- Isolates of Neisseria meningitidis and Neisseria gonorrhoeae Induce Sustained Proliferative Responses in Human CD4+ T Cells
Abdel-Rahman Youssef et al.
INFECTION AND IMMUNITY (2009)
Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response
V. Weynants et al.
INFECTION AND IMMUNITY (2009)
Opa protein repertoires of disease-causing and carried meningococci
Martin J. Callaghan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing
L. F. Baethgen et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Clustal W and clustal X version 2.0
M. A. Larkin et al.
BIOINFORMATICS (2007)
Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function
Hannah S. W. Lee et al.
INFECTION AND IMMUNITY (2007)
Co-ordinate action of bacterial adhesins and human carcinoembryonic antigen receptors in enhanced cellular invasion by capsulate serum resistant Neisseria meningitidis
Helen A. Rowe et al.
CELLULAR MICROBIOLOGY (2007)
Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene-positive meningococci isolated from healthy carriers
Martin V. R. Weber et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis
Martin J. Callaghan et al.
INFECTION AND IMMUNITY (2006)
Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit
Stephen J. Gray et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB
DR Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Critical determinants of the interactions of capsule-expressing Neisseria meningitidis with host cells:: the role of receptor density in increased cellular targeting via the outer membrane Opa proteins
CJ Bradley et al.
CELLULAR MICROBIOLOGY (2005)
Recognition of saccharides by the OpcA, OpaD, and OpaB outer membrane proteins from Neisseria meningitidis
J Moore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination
M Fisseha et al.
INFECTION AND IMMUNITY (2005)
MeNZB™:: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
P Oster et al.
VACCINE (2005)
Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins
MI de Jonge et al.
VACCINE (2004)
Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease
G Norheim et al.
VACCINE (2004)
Analysis of the role of pglI in pilin glycosylation of Neisseria meningitidis
MJ Warren et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine
JA Welsch et al.
JOURNAL OF IMMUNOLOGY (2004)
Neisserial Opa proteins: Impact on colonization, dissemination and immunity
SD Gray-Owen
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis
MI de Jonge et al.
INFECTION AND IMMUNITY (2003)
Conformational analysis of opacity proteins from Neisseria meningitidis
MI de Jonge et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4(+) T lymphocytes
IC Boulton et al.
NATURE IMMUNOLOGY (2002)
Insertion-duplication mutagenesis of Neisseria:: Use in characterization of DNA transfer genes in the gonococcal genetic island
HL Hamilton et al.
JOURNAL OF BACTERIOLOGY (2001)
Medical progress: Meningococcal disease.
NE Rosenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58
H Tettelin et al.
SCIENCE (2000)
Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491
J Parkhill et al.
NATURE (2000)
Share Paper
